Metabolomics means indentification and quantification of cellular metabolites with the help of refined analytical technologies. Metabolomics involves usage of multi-variant and statistical methods for understanding data as well as information mining. Metabolomics gives a direct functional information of the physiological state of an organism and is used in bridging the gap between phenotype and genotype by providing a total and complete view of the functioning of a cell along with identification of novel alterations in certain metabolites. Various advanced analytical technologies are introduced and are employed to examine metabolites in different tissues, organisms or fluids. These small molecules and their interactions in the respective biological system are known as metabolomes. Since metabolomics involves the study of products of metabolism and substrates, it is generally affected by environmental and genetic factors. Metabolomics find a wide range of applications including determination of gene functioning, phenotyping of genetically modified plants and respective equivalence testing and monitoring responses to abiotic and biotic stress. Metabolomics is used as an important life science tool since it is a comparatively precise and fast technique that can be either applied with a particular focus or in an overall manner to gain knowledge on various biological systems. Metabolomics find importance in genomic studies since it controls the functions of unknown genes since the changes associated with small molecules concentrations are closely attached with the detected phenotype.
The global metabolomics market is majorly driven due to increasing demand for personalized medicines. Moreover, increasing government funding and organizational initiatives, especially in Europe and North America is a key factor fueling the growth of metabolomics market. Increasing necessity for improved research and development facilities along with rising investments in toxicology technologies across pharmaceutical and biotechnology sectors are some key factors propelling the growth of global metabolomics market. Since personalized health care facilities facilitates in providing information to detect the onset of diseases at an earlier stage, it prevents the progression of disease as well as increases the effectiveness of healthcare system by refining the overall availability, quality and affordability, thus driving the global metabolomics market. Increasing prevalence of chronic degenerative diseases such as neurodegenerative diseases, cardiovascular diseases, cancer etc. is a key opportunities for the growth of metabolomics market. Also, growing unmet medical demands is in turn creating the demand for personalized medication facilities across the globe, thus driving the market for metabolomics. However, lack of standardized protocols and data complexity are some major factors hindering the growth of global metabolomics market. Moreover, shortage of skilled personnel in the field of metabolomics and unavailability of complete metabolite libraries are some important factors hampering the market growth.
The global metabolomics market can be segmented on the basis of technique, indication, application and geography. On the basis of technique, the global metabolomics market can be segmented into separation techniques and detection techniques. Separation techniques segment can be further sub-segmented into gas chromatography, ultra performance liquid chromatography, capillary electrophoresis, and high performance liquid chromatography. The detection techniques segment is further sub-segmented into mass spectrometry, surface based mass analysis and nuclear magnetic resource spectroscopy. On the basis of application, the global metabolomics market can be segmented into drug discovery, toxicology testing, nutrigenomics, biomarker discovery and others. On the basis of indication the global metabolomics market can be segmented into cardiology, neurology, oncology and others. On the basis of geography, the global metabolomics market can be segmented into North America, Latin America, Europe, Middle East & Africa and Asia-Pacific.
Key players involved in the manufacture of metabolomic devices include Thermo Fisher Scientific Inc., Biocrates Life Sciences AG, Human Metabolome Technologies Inc., Metabolon Inc., Bruker Corporation, LECO Corporation, Waters Corporation, Agilent Technologies, Bio-Rad laboratories Inc., Shimadzu Corporation and others.
Market by Technique
· Separation techniques
o Gas chromatography
o Ultra performance liquid chromatography
o Capillary electrophoresis
o High performance liquid chromatography
· Detection techniques
o Mass spectrometry
o Surface based mass analysis
o Nuclear magnetic resource spectroscopy
Market by Indication
Market by Application
· Drug discovery
· Toxicology testing
· Biomarker discovery
Market by Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Introduction Blood clot retrieval is a surgical technique that involves mechanical removal of blood clot from the patient’s brain. This technique is mainly used for the treatment of ischemic strokes caused due to the blood clots, which reduces the risk of...
Introduction Diabetes is a metabolic disease in which consist of elevated blood glucose levels over a prolonged period. It is caused due to either pancreas not able to produce enough insulin or cells of the body not responding to the insulin produced. Insulin m...
Introduction A number of different types of nutrition are for infants are available in the market. The infant formulas comprise of purified cow’s milk as a source of protein, blend of fat source form vegetable oils, vitamin-mineral mix, lactose as a carbo...
Introduction Prefilled syringes are ready-to-use pharmaceutical products used to deliver the medication to the patients. They are disposable syringes which contain substance or liquid use to administered to a patient. These syringes deliver the accurate dose of...
Introduction Digital pill is a pharmaceutical dosage form and it is consists of ingestible sensor inside of a pill. A small, swallowable sensor named AbilifyMyCite that tracks path when the patient swallows their medicines. The tablet is precisely targeted for ...
Introduction Fish Collagen Hydrolyzed is mass-produced from collagen and it is the primary protein originates from bones and skin. Animal collagen is naturally extracted from porcine orbovine skin whereas fish collagen is made from the skin of ocean ordeep wate...